User banner image
User avatar
  • admin

Posts

Arcadium Lithium Releases Fourth Quarter and Full Year 2024 Results

PHILADELPHIA and PERTH, Australia, Feb. 28, 2025 /PRNewswire/ — Arcadium Lithium plc (NYSE: ALTM, ASX: LTM, “Arcadium Lithium” or the “Company”) today reported results for the fourth...

Smarter, Slimmer, and More Powerful: Roborock Saros 10 Revolutionises Home Cleaning in Australia

SYDNEY, Feb. 28, 2025 /PRNewswire/ — Following its global debut at CES earlier this year, Roborock, a global leader in ultra-intelligent home robotics, announces the...

New Canopus SEER Platform Gives Ultimate Control over Data Powering AI Agents

Agentic-AI, real-time network observability platform with programmable sensors and curated data streams enables network teams to see every user and application experience in Ultra-HD clarity SAN...

Bleaching Agents Market Research Report 2025-2033, Featuring Detailed Analysis of Key Players – BASF, Aditya Birla Chemicals, Evonik, Solvay, AkzoNobel & More

Increasing Investments in Wastewater Treatment Plants by Governments Significantly Contributing to Market Growth Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) — The “Bleaching Agents Market by...

Returnable Transport Packaging Market to Reach USD 50.17 Billion by 2035, Driven by Sustainability and Supply Chain Efficiency | Future Market Insights, Inc.

Germany’s returnable transport packaging market is driven by the auto industry’s shift to standardized reusable packaging for efficiency and sustainability. Leading carmakers like Volkswagen, BMW,...

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Initial clinical data from global Phase 1 study of CLN-978 in Systemic Lupus Erythematosus (SLE) expected in Q4 2025; CLN-978 remains the first and only...

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for completion of last patient visit in the open-label extension in Q1...

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total...

Remix Therapeutics Announces Participation in Leerink Global Healthcare Conference

WATERTOWN, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) — Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address...

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor...